InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Sunday, 03/30/2014 9:05:40 PM

Sunday, March 30, 2014 9:05:40 PM

Post# of 346112
How many press releases next week? And then there are the AACR posters beginning April 6.

Apr 5–9, 2014 AACR Annual Meeting, San Diego, CA


Poster Title:
"Antibody-mediated blockade of phosphatidylserine combined with radiation improves survival and tumor eradication in a rat model of non-small cell lung cancer"

Olivier Belzile, Zhang Zhang, Xianming Huang, Debabrata Saha, Rolf A. Brekken, University of Texas Southwestern Medical Center, Dallas, TX
Poster Session: PO.IM02.03. Immune Mechanisms Invoked by Radiation, Chemotherapy, or Targeted Therapy

Sun, Apr 6, 1:00 - 5:00 PM



Poster Title:
"Targeting of Phosphatidylserine by Monoclonal Antibodies Enhances Activity of Immune Checkpoint Inhibitors in Tumors"

Jian Gong, Van Nguyen, Shen Yin, Rich Archer, Jeff Hutchins, Bruce Freimark. Peregrine Pharmaceuticals, Inc., Tustin, CA
Poster Session: PO.TB06.08. Tumor Microenvironment

Wed, Apr 9, 8:00 AM - 12:00 PM



Poster Title:
"Phosphatidylserine-targeting antibody synergizes with anti-PD-1 antibody to inhibit tumor growth in K1735 mouse melanoma model"

Xianming Huang, Dan Ye, Rolf Brekken, Yi Yin. UT Southwestern Medical Ctr., Dallas, TX
Late-Breaking Poster Session: LBPO.IM01. Late-Breaking Research: Immunology

Tue, Apr 8, 1:00 - 5:00 PM



"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News